3-amido substituted nenzoyl urea compound, and its antitumor action
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
- Publication Date
- 2006-10-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to a microtubule microfilament inhibitor benzoylurea small molecule derivative and its antitumor effect. Background technique:
[0002] Tumor is one of the malignant and stubborn diseases that are difficult to deal with, and it has become the second "killer" in the world after cardiovascular disease. According to the statistics of the World Health Organization, in 2000, the number of new cancer cases in the world exceeded 10 million, and the number of deaths was 6.2 million. In 2004, the number of patients exceeded 22 million. In 2020, the number of new cancer cases worldwide will reach 15 million and 10 million will die. According to literature reports, in addition to the bioengineering drugs (including anti-cancer vaccines) such as monoclonal antibodies, tumor necrosis factors, interferons, and interleukins that have been marketed, the anti-tumor drugs that are currently under development include the following 8 categories: ①A...